nach oben

Current Neurology and Neuroscience Reports

Erschienen in:

01.04.2020 | Pediatric Neurology (WE Kaufmann, Section Editor)

EEG Monitoring of the Epileptic Newborn

verfasst von: Francesco Pisani, Carlotta Spagnoli, Carlo Fusco

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Although differentiating neonatal-onset epilepsies from acute symptomatic neonatal seizures has been increasingly recognized as crucial, existing guidelines, and recommendations on EEG monitoring are mainly based on acute symptomatic seizures, especially secondary to hypoxic-ischemic encephalopathy. We aimed to narratively review current knowledge on neonatal-onset epilepsies of genetic, metabolic, and structural non-acquired origin, with special emphasis on EEG features and monitoring.

Recent Findings

A wide range of rare conditions are increasingly described, reducing undiagnosed cases. Although distinguishing features are identifiable in some, how to best monitor and detect less described etiologies is still an issue. A comprehensive approach considering onset, seizure evolution, ictal semiology, clinical, laboratory, EEG, and neuroimaging data is key to diagnosis.

Summary

Phenotypic variability prevents precise recommendations, but a solid, consistent method moving from existing published guidelines helps in correctly assessing these newborns in order to provide better care, especially in view of expanding precision therapies.

Pisani F, Cerminara C, Fusco C, Sisti L. Neonatal status epilepticus vs recurrent neonatal seizures: clinical findings and outcome. Neurology. 2007;69:2177–85.PubMed

• Pisani F, et al. Incidence of neonatal seizures, perinatal risk factors for epilepsy and mortality after neonatal seizures in the province of Parma, Italy. Epilepsia. 2018;59:1764–73 Recent population-based study on neonatal seizures incidence and risk factors for mortality and epilepsy.PubMed

Shellhaas RA. Seizure classification, etiology, and management. Handb Clin Neurol. 2019;162:347–61.PubMed

Lynch NE, Stevenson NJ, Livingstone V, Mathieson S, Murphy BP, Rennie JM, et al. The temporal characteristics of seizures in neonatal hypoxic ischemic encephalopathy treated with hypothermia. Seizure. 2015;33:60–5.PubMed

Andreolli A, Turco EC, Pedrazzi G, Beghi E, Pisani F. Incidence of epilepsy after neonatal seizures: a population-based study. Neuroepidemiology. 2019;52(3–4):144–51.PubMed

Shellhaas RA, Chang T, Tsuchida T, Scher MS, Riviello JJ, Abend NS, et al. The American clinical neurophysiology Society's guideline on continuous electroencephalography monitoring in neonates. J Clin Neurophysiol. 2011;28(6):611–7.PubMed

Ramantani G, Schmitt B, Plecko B, Pressler RM, Wohlrab G, Klebermass-Schrehof K, et al. Neonatal seizures-are we there yet? Neuropediatrics. 2019;50(5):280–93.PubMed

• Cornet MC, Sands TT, Cilio MR. Neonatal epilepsies: clinical management. Semin fetal neonatal med. 2018;23(3):204–12 A review article addressing the clinical features and therapeutic strategies for neonatal-onset epilepsies.PubMed

Axeen EJT, Olson HE. Neonatal epilepsy genetics. Semin Fetal Neonatal Med. 2018;23(3):197–203.PubMed

10.

Pisani F, Sisti L, Seri S. A scoring system for early prognostic assessment after neonatal seizures. Pediatrics. 2009;124(4):e580–7.PubMed

11.

Cornet MC, Cilio MR. Genetics of neonatal-onset epilepsies. Handb Clin Neurol. 2019;162:415–33.PubMed

12.

Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512–21.PubMedPubMedCentral

13.

Hellström-Westas L, Boylan G, Ågren J. Systematic review of neonatal seizure management strategies provides guidance on anti-epileptic treatment. Acta Paediatr. 2015;104(2):123–9.PubMed

14.

McCoy B, Hahn CD. Continuous EEG monitoring in the neonatal intensive care unit. J Clin Neurophysiol. 2013;30(2):106–14.PubMed

15.

de Vries LS, Hellström-Westas L. Role of cerebral function monitoring in the newborn. Arch Dis Child Fetal Neonatal Ed. 2005;90(3):F201–7.PubMedPubMedCentral

16.

Abend NS, Wusthoff CJ. Neonatal seizures and status epilepticus. J Clin Neurophysiol. 2012;29(5):441–8.PubMedPubMedCentral

17.

Laroia N, Guillet R, Burchfiel J, McBride MC. EEG background as predictor of electrographic seizures in high-risk neonates. Epilepsia. 1998;39(5):545–51.PubMed

18.

Battin M, Bennet L, Gunn AJ. Rebound seizures during rewarming. Pediatrics. 2004;114(5):1369.PubMed

19.

Glass HC, Wusthoff CJ, Shellhaas RA, Tsuchida TN, Bonifacio SL, Cordeiro M, et al. Risk factors for EEG seizures in neonates treated with hypothermia: a multicenter cohort study. Neurology. 2014;82(14):1239–44.PubMedPubMedCentral

20.

Shah DK, Zempel J, Barton T, Lukas K, Inder TE. Electrographic seizures in preterm infants during the first week of life are associated with cerebral injury. Pediatr Res. 2010;67(1):102–6.PubMed

21.

Gupta SN, Kechli AM, Kanamalla US. Intracranial hemorrhage in term newborns: management and outcomes. Pediatr Neurol. 2009;40(1):1–12.PubMed

22.

Chequer RS, Tharp BR, Dreimane D, Hahn JS, Clancy RR, Coen RW. Prognostic value of EEG in neonatal meningitis: retrospective study of 29 infants. Pediatr Neurol. 1992;8(6):417–22.PubMed

23.

Murray DM, Boylan GB, Ali I, Ryan CA, Murphy BP, Connolly S. Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed. 2008;93(3):F187–91.PubMed

24.

Clancy RR, Sharif U, Ichord R, Spray TL, Nicolson S, Tabbutt S, et al. Electrographic neonatal seizures after infant heart surgery. Epilepsia. 2005;46(1):84–90.PubMed

25.

Pisani F, Barilli AL, Sisti L, Bevilacqua G, Seri S. Preterm infants with video-EEG confirmed seizures: outcome at 30 months of age. Brain and Development. 2008;30(1):20–30.PubMed

26.

Orivoli S, Facini C, Pisani F. Paroxysmal nonepileptic motor phenomena in newborn. Brain and Development. 2015;37(9):833–9.PubMed

27.

Kotulska K, Jurkiewicz E, Domańska-Pakieła D, Grajkowska W, Mandera M, Borkowska J, et al. Epilepsy in newborns with tuberous sclerosis complex. Eur J Paediatr Neurol. 2014;18(6):714–21.PubMed

28.

French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016;388(10056):2153–63.PubMed

29.

Shoubridge C, Fullston T, Gecz J. ARX spectrum disorders: making inroads into the molecular pathology. Hum Mutat. 2010;31:889–900.PubMed

30.

D'Gama AM, Geng Y, Couto JA, Martin B, Boyle EA, LaCoursiere C, et al. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia. Ann Neurol. 2015;77(4):720–5.PubMedPubMedCentral

31.

John S, Jehi L, Manno EM, Conway DS, Uchino K. COL4A1 gene mutation: beyond a vascular syndrome. Seizure. 2015;31:19–21.PubMed

32.

Sands TT, Balestri M, Bellini G, Mulkey SB, Danhaive O, Bakken EH, et al. Rapid and safe response to low-dose carbamazepine in neonatal epilepsy. Epilepsia. 2016;57(12):2019–30.PubMed

33.

Weckhuysen S, Mandelstam S, Suls A, Audenaert D, Deconinck T, Claes LR, et al. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. Ann Neurol. 2012;71(1):15–25.PubMed

34.

Numis AL, et al. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response. Neurology. 2014;82(4):368–70.PubMedPubMedCentral

35.

Pisano T, Numis AL, Heavin SB, Weckhuysen S, Angriman M, Suls A, et al. Early and effective treatment of KCNQ2 encephalopathy. Epilepsia. 2015;56(5):685–91.PubMed

36.

Olson HE, Kelly M, LaCoursiere C, Pinsky R, Tambunan D, Shain C, et al. Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppression. Ann Neurol. 2017;81:419–29.PubMedPubMedCentral

37.

Lauritano A, Moutton S, Longobardi E, Tran Mau-Them F, Laudati G, Nappi P, et al. A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy. Epilepsia Open. 2019;4(3):464–75.PubMedPubMedCentral

38.

Wolff M, Johannesen KM, Hedrich UBS, Masnada S, Rubboli G, Gardella E, et al. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain. 2017;140(5):1316–36.PubMed

39.

Barcia G, Fleming MR, Deligniere A, Gazula VR, Brown MR, Langouet M, et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet. 2012;44(11):1255–9.PubMedPubMedCentral

40.

Štěrbová K, Vlčková M, Klement P, Neupauerová J, Staněk D, Zůnová H, et al. Neonatal onset of epilepsy of infancy with migrating focal seizures associated with a novel GABRB3 variant in monozygotic twins. Neuropediatrics. 2018;49:204–8.PubMed

41.

Milligan CJ, Li M, Gazina EV, Heron SE, Nair U, Trager C, et al. KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine. Ann Neurol. 2014;75(4):581–90.PubMedPubMedCentral

42.

Allen AS, et al. De novo mutations in epileptic encephalopathies. Nature. 2013;501:217–21.PubMed

43.

Hernandez CC, XiangWei W, Hu N, Shen D, Shen W, Lagrange AH, et al. Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies. Brain. 2019;142(7):1938–54.PubMed

44.

Epi4K Consortium. De novo mutations in SLC1A2 and CACNA1A are important causes of epileptic encephalopathies. Am J Hum Genet. 2016;99:287–98.

45.

Bozarth X, Dines JN, Cong Q, Mirzaa GM, Foss K, Lawrence Merritt J 2nd, et al. Expanding clinical phenotype in CACNA1C related disorders: from neonatal onset severe epileptic encephalopathy to late-onset epilepsy. Am J Med Genet A. 2018;176(12):2733–9.PubMedPubMedCentral

46.

Reinson K, Õiglane-Shlik E, Talvik I, Vaher U, Õunapuu A, Ennok M, et al. Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy. Am J Med Genet A. 2016;170(8):2173–6.PubMed

47.

Shimomura K, Hörster F, de Wet H, Flanagan SE, Ellard S, Hattersley AT, et al. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain. Neurology. 2007;69(13):1342–9.PubMed

48.

Guella I, Huh L, McKenzie M, Toyota EB, Bebin EM, Thompson ML, et al. De novo FGF12 mutation in 2 patients with neonatal-onset epilepsy. Neurol Genet. 2016;2(6):e120.PubMedPubMedCentral

49.

Olson HE, et al. A recurrent De novo PACS2 heterozygous missense variant causes neonatal-onset developmental epileptic encephalopathy, facial Dysmorphism, and cerebellar Dysgenesis. Am J Hum Genet. 2018;103(4):631.PubMedPubMedCentral

50.

Saitsu H, Kato M, Mizuguchi T, Hamada K, Osaka H, Tohyama J, et al. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet. 2008;40:782–8.PubMed

51.

Tohyama J, et al. SPTAN1 encephalopathy: distinct phenotypes and genotypes. J Hum Genet. 2015;60:167e73.

52.

Syrbe S, Harms FL, Parrini E, Montomoli M, Mütze U, Helbig KL, et al. Delineating SPTAN1 associated phenotypes: from isolated epilepsy to encephalopathy with progressive brain atrophy. Brain. 2017;140(9):2322–36.PubMedPubMedCentral

53.

Guerrero-López R, Ortega-Moreno L, Giráldez BG, Alarcón-Morcillo C, Sánchez-Martín G, Nieto-Barrera M, et al. Atypical course in individuals from Spanish families with benign familial infantile seizures and mutations in the PRRT2 gene. Epilepsy Res. 2014;108(8):1274–8.PubMed

54.

Ebrahimi-Fakhari D, Saffari A, Westenberger A, Klein C. The evolving spectrum of PRRT2-associated paroxysmal diseases. Brain. 2015;138(Pt 12):3476–95.PubMed

55.

Maini I, Iodice A, Spagnoli C, Salerno GG, Bertani G, Frattini D, et al. Expanding phenotype of PRRT2 gene mutations: a new case with epilepsy and benign myoclonus of early infancy. Eur J Paediatr Neurol. 2016;20(3):454–6.PubMed

56.

Balestrini S, Milh M, Castiglioni C, Lüthy K, Finelli MJ, Verstreken P, et al. TBC1D24 genotype-phenotype correlation: epilepsies and other neurologic features. Neurology. 2016;87:77–85.PubMedPubMedCentral

57.

Hansen J, Snow C, Tuttle E, Ghoneim DH, Yang CS, Spencer A, et al. De novo mutations in SIK1 cause a spectrum of developmental epilepsies. Am J Hum Genet. 2015;96:682–90.PubMedPubMedCentral

58.

Klein KM, Yendle SC, Harvey AS, Antony JH, Wallace G, Bienvenu T, et al. A distinctive seizure type in patients with CDKL5 mutations: Hypermotor-tonic-spasms sequence. Neurology. 2011;76(16):1436–8.PubMed

59.

Melani F, Mei D, Pisano T, Savasta S, Franzoni E, Ferrari AR, et al. CDKL5 gene-related epileptic encephalopathy: electroclinical findings in the first year of life. Dev Med Child Neurol. 2011;53:354–60.PubMed

60.

Bahi-Buisson N, Kaminska A, Boddaert N, Rio M, Afenjar A, Gérard M, et al. The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia. 2008;49(6):1027–37.PubMed

61.

Feng H, Sjogren B, Karaj B, Shaw V, Gezer A, Neubig RR. Movement disorder in GNAO1 encephalopathy associated with gain-of-function mutations. Neurology. 2017;89:762–70.PubMedPubMedCentral

62.

Horn D, Weschke B, Knierim E, Fischer-Zirnsak B, Stenzel W, Schuelke M, et al. BRAT1 mutations are associated with infantile epileptic encephalopathy, mitochondrial dysfunction, and survival into childhood. Am J Med Genet A. 2016;170:2274–81.PubMed

63.

Srivastava S, et al. BRAT1 mutations present with a spectrum of clinical severity. Am J Med Genet A. 2016;170(9):2265–73.PubMedPubMedCentral

64.

Dilena R, DiFrancesco J, Soldovieri MV, Giacobbe A, Ambrosino P, Mosca I, et al. Early treatment with quinidine in 2 patients with epilepsy of infancy with migrating focal seizures (EIMFS) due to gain-of-function KCNT1 mutations: functional studies, clinical responses, and critical issues for personalized therapy. Neurotherapeutics. 2018;15(4):1112–26.PubMedPubMedCentral

65.

Mills PB, Struys E, Jakobs C, Plecko B, Baxter P, Baumgartner M, et al. Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med. 2006;12:307–9.PubMed

66.

Kuo MF, Wang HS. Pyridoxal phosphate-responsive epilepsy with resistance to pyridoxine. Pediatr Neurol. 2002;26(2):146–7.PubMed

67.

Plecko B, Zweier M, Begemann A, Mathis D, Schmitt B, Striano P, et al. Confirmation of mutations in PROSC as a novel cause of vitamin B 6-dependent epilepsy. J Med Genet. 2017;54:809–14.PubMed

68.

Guzel Nur B, et al. Pyridoxine-responsive seizures in infantile hypophosphatasia and a novel homozygous mutation in ALPL gene. J Clin Res Pediatr Endocrinol. 2016;8:360e4.

69.

Van Hove J, Coughlin C II, Scharer G. Glycine Encephalopathy. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors.

70.

Bruun TUJ, DesRoches C, Wilson D, Chau V, Nakagawa T, Yamasaki M, et al. Prospective cohort study for identification of underlying genetic causes in neonatal encephalopathy using whole-exome sequencing. Genet Med. 2018;20(5):486–94.PubMed

71.

Mastrangelo M. Actual insights into treatable inborn errors of metabolism causing epilepsy. J Pediatr Neurosci. 2018;13(1):13–23.PubMedPubMedCentral

72.

Atwal PS, Scaglia F. Molybdenum cofactor deficiency. Mol Genet Metab. 2016 Jan;117(1):1–4.PubMed

73.

Schwahn BC, van Spronsen F, Belaidi AA, Bowhay S, Christodoulou J, Derks TG, et al. Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type a: a prospective cohort study. Lancet. 2015;386(10007):1955–63.PubMed

74.

Sass JO, Gunduz A, Araujo Rodrigues Funayama C, Korkmaz B, Dantas Pinto KG, Tuysuz B, et al. Functional deficiencies of sulfite oxidase: differential diagnoses in neonates presenting with intractable seizures and cystic encephalomalacia. Brain and Development. 2010;32:544–9.PubMed

75.

Bindu PS, Nagappa M, Bharath RD, Taly AB. Isolated sulfite oxidase deficiency. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews [internet]. Seattle (WA): University of Washington, Seattle; 2017. p. 1993–2020.

76.

Honzik T, Tesarova M, Magner M, Mayr J, Jesina P, Vesela K, et al. Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis. J Inherit Metab Dis. 2012;35:749–59.PubMed

77.

Kodera H, Nakamura K, Osaka H, Maegaki Y, Haginoya K, Mizumoto S, et al. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy. Hum Mutat. 2013;34:1708–14.PubMed

78.

Kato M, et al. PIGA mutations cause early-onset epileptic encephalopathies and distinctive features. Neurology. 2014;82:1587e96.

79.

Bayat A, Knaus A, Juul AW, Dukic D, Gardella E, Charzewska A, et al. PIGT-CDG, a disorder of the glycosylphosphatidylinositol anchor: description of 13 novel patients and expansion of the clinical characteristics. Genet Med. 2019;21(10):2216–23.PubMed

80.

Yates TM, Suri M, Desurkar A, Lesca G, Wallgren-Pettersson C, Hammer TB, et al. SLC35A2-related congenital disorder of glycosylation: defining the phenotype. Eur J Paediatr Neurol. 2018;22(6):1095–102.PubMed

81.

Hardies K, de Kovel CG, Weckhuysen S, Asselbergh B, Geuens T, Deconinck T, et al. Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia. Brain. 2015;138:3238–50.PubMed

82.

• Nunes ML, et al. Neonatal seizures: is there a relationship between ictal electroclinical features and etiology? A critical appraisal based on a systematic literature review. Epilepsia open. 2019;4(1):10–29 A recent review paper critically summarizing data on the controversial relationship between ictal semiology and etiology.PubMedPubMedCentral

83.

Rennie JM, de Vries LS, Blennow M, Foran A, Shah DK, Livingstone V, et al. Characterisation of neonatal seizures and their treatment using continuous EEG monitoring: a multicentre experience. Arch Dis Child Fetal Neonatal Ed. 2019;104(5):F493–501.PubMed

Titel: EEG Monitoring of the Epileptic Newborn
verfasst von: Francesco Pisani
Carlotta Spagnoli
Carlo Fusco
Publikationsdatum: 01.04.2020
Verlag: Springer US
Erschienen in: Current Neurology and Neuroscience Reports / Ausgabe 4/2020
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI: https://doi.org/10.1007/s11910-020-1027-7

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

EEG Monitoring of the Epileptic Newborn

Abstract

Purpose of Review

Recent Findings

Summary

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie